CLINICAL_TRIALS
trial_result
· 2024-09-27
Clinical Trial Update: FIRMAGON® Intensive Drug Monitoring
Summary
Results from an intensive drug monitoring study of FIRMAGON (degarelix) in prostate cancer have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2024-09-27